Focusing on Applications of Innovative Cryotherapy Technologies

SensCure is a high-tech enterprise of medical device based on innovation, integration of independent research and development, production and commercialization. The Company is strong in research and development, and has a high-caliber and professional R&D team. It also owns a number of patent licenses. At present, the Company has passed the ISO13485 Quality Management System certification, and has regulatory approvals in China and European Union for a number of products.
Know more
Latest Information
2025-03-06 行业资讯
国际首个呼吸介入球囊冷冻消融系统已获批
2025年3月6日,宁波胜杰康生物科技有限公司自主研发的恶性狭窄冷冻消融系统(包含“一次性使用气道冷冻消融导管”和“冷冻治疗设备”) 获得国家药品监督管理局(NMPA)批准上市(导管注册证号:国械注准20253010479;设备注册证号: 国械注准20253010490)。此次获批上市的冷冻消融系统是胜杰康呼吸疾病系列冷冻消融中的第一个产品,用于冷冻消融气道肿瘤组织、减少气道再狭窄频次的
Know more
2024-07-01 行业资讯
康沣生物与波科国际医疗贸易(上海)有限公司的业务合作
2024年7月1日,康沣生物与波科国际医疗贸易(上海)有限公司的中国大陆呼吸介入产品订立经销协议。波科国际医疗贸易(上海)有限公司为Boston Scientific Corporation(一家于纽约证券交易所上市的公司(股份代号:BSX))于中国的附属公司。Boston Scientific是全球医疗技术领导者,通过提供广泛的高性能解决方案来满足患者需求并降低医疗
Know more
2024-04-17 行业资讯
胜杰康亮相2024上海消化内镜学术大会暨第十六届中日ESD论坛
为全面展现消化内镜领域最新诊疗技术和研究成果,规范消化内镜诊断和微创切除技术操作,推进国内镜诊治水平的发展,“上海国际消化内镜研讨会暨第十六届中日ESD高峰论坛”于2024年4月13至14日为期两天在上海国际会议中心成功召开,参会嘉宾382位,包括4位院士,主会场总演讲33场,包含国际嘉宾8场,手术数量52台。大会共设14个分会场,报名参会代表1405人,到场参会人员共计3681人次,线上观看总人次181496人次,现已圆满落幕。
Know more
Specialize in innovative minimally invasive technologies
Strive to improve and extend people’s life
We constantly provide the market with high-quality products and make unremitting efforts for the cause of human health.
Know more
+86 574-6372-9798
overseas@senscure.net
Building 3, Area B, No. 777, Binhai 4th Road, Hangzhou Bay New District, Ningbo City, Zhejiang Province
Copyright ©2022 Ningbo SensCure Biotechnology Co., Ltd.. All Rights Reserved